Dr Shaun Frost
Early detection of Alzheimer's disease using ocular biomarkers
Alzheimer's disease & other dementias
alzheimer disease | biomarkers | early detection | retina | ocular disease
Curcumin fluorescence imaging of the retina will be tested for quantification of retinal amyloid plaque burden and rate of change. This will be compared to AD disease status, brain plaque burden and other markers to evaluate retinal imaging as an early test for AD.